Active immunization against cancer with dendritic cells: The near future

No abstract is available for this paper.

• Publication year

  2001

• Venue

  International Journal of Cancer

• Publication date

  2001-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.1503PMID 11745430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer vaccines

  2005cited by this paper
• Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions1

  2001cited by this paper
• Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential.

  2001cited by this paper
• Viral vectors for dendritic cell-based immunotherapy.

  2001cited by this paper
• Production of IL-12 by Human Monocyte-Derived Dendritic Cells Is Optimal When the Stimulus Is Given at the Onset of Maturation, and Is Further Enhanced by IL-41

  2001cited by this paper
• Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow

  2001cited by this paper
• Autologous dendritic cells for treatment of advanced cancer--an update.

  2001cited by this paper
• Differentiation of T Regulatory Cells by Immature Dendritic Cells

  2001cited by this paper
• Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients.

  2001cited by this paper
• PD-L2 is a second ligand for PD-1 and inhibits T cell activation

  2001cited by this paper
• Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

  2001cited by this paper
• Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+and CD4+ T-Cell Responses from Chronically Infected Individuals

  2001cited by this paper
• The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function

  2001cited by this paper
• Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes.

  2001cited by this paper
• B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.

  2001cited by this paper
• Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.

  2001cited by this paper
• Cervical cancer vaccines: Emerging concepts and developments

  2001cited by this paper
• Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells

  2001cited by this paper
• Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens

  2001cited by this paper
• Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

  2001cited by this paper
• Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

  2001cited by this paper
• EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.

  2001cited by this paper
• Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression.

  2001cited by this paper
• Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1

  2001cited by this paper
• A comparison of two types of dendritic cell as adjuvants for the induction of melanoma‐specific T‐cell responses in humans following intranodal injection

  2001cited by this paper
• Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

  2001cited by this paper
• Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients1

  2001cited by this paper
• B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells

  2001cited by this paper
• IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

  2001cited by this paper
• Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents.

  2001cited by this paper
• The cell biology of antigen presentation in dendritic cells.

  2001cited by this paper
• Viral vectors for dendritic cell-based immunotherapy.

  2001cited by this paper
• Dendritic cell-based immunotherapy of renal cell carcinoma

  2001cited by this paper
• B7-H3: A costimulatory molecule for T cell activation and IFN-γ production

  2001cited by this paper
• Assessing Cd8 T Cell Number and Dysfunction in the Presence of Antigen

  2001cited by this paper
• Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

  2001cited by this paper
• ICOS is essential for effective T-helper-cell responses

  2001cited by this paper
• Cd40-Independent Pathways of T Cell Help for Priming of Cd8+ Cytotoxic T Lymphocytes

  2000cited by this paper
• Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.

  2000cited by this paper
• Phase I study in melanoma patients of a vaccine with peptide‐pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells

  2000cited by this paper
• Transport of peptide-MHC class II complexes in developing dendritic cells.

  2000cited by this paper
• Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers

  2000cited by this paper
• Retrovirally Transduced Mouse Dendritic Cells Require CD4+ T Cell Help to Elicit Antitumor Immunity: Implications for the Clinical Use of Dendritic Cells1

  2000cited by this paper
• Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

  2000cited by this paper
• Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells

  2000cited by this paper
• Interleukin (Il)-4 Is a Major Regulatory Cytokine Governing Bioactive IL-12 Production by Mouse and Human Dendritic Cells

  2000cited by this paper
• Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response.

  2000cited by this paper
• DNA vaccines: immunology, application, and optimization*.

  2000cited by this paper
• CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity1

  2000cited by this paper
• A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.

  2000cited by this paper
• Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids

  2000cited by this paper
• The Formation of Immunogenic Major Histocompatibility Complex Class II–Peptide Ligands in Lysosomal Compartments of Dendritic Cells Is Regulated by Inflammatory Stimuli

  2000cited by this paper
• Fusions of Human Ovarian Carcinoma Cells with Autologous or Allogeneic Dendritic Cells Induce Antitumor Immunity1

  2000cited by this paper
• Eradication of established tumors by CD8+ T cell adoptive immunotherapy.

  2000cited by this paper
• Bacterial CpG‐DNA activates dendritic cells in vivo: T helper cell‐independent cytotoxic T cell responses to soluble proteins

  2000cited by this paper
• Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

  2000cited by this paper
• Human skin Langerhans cells are targets of dengue virus infection

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• Cd40–Cd40 Ligand Interactions in Vivo Regulate Migration of Antigen-Bearing Dendritic Cells from the Skin to Draining Lymph Nodes

  2000cited by this paper
• Dendritic Cells, Infected with Vesicular Stomatitis Virus-Pseudotyped HIV-1, Present Viral Antigens to CD4+ and CD8+ T Cells from HIV-1-Infected Individuals1

  2000cited by this paper
• Present difficulties and future promise of MHC multimers in autoimmune exploration.

  2000cited by this paper
• Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

  2000cited by this paper
• Cutting Edge: Heat Shock Protein gp96 Induces Maturation and Migration of CD11c+ Cells In Vivo1

  2000cited by this paper
• A Subset of Cytolytic Dendritic Cells in Rat1

  2000cited by this paper
• Corpse clearance defines the meaning of cell death

  2000cited by this paper
• Consequences of Cell Death

  2000cited by this paper
• Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes.

  2000cited by this paper
• Efficient Expression of the Tumor-Associated Antigen MAGE-3 in Human Dendritic Cells, Using an Avian Influenza Virus Vector

  2000cited by this paper
• Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo

  2000cited by this paper
• DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

  2000cited by this paper
• Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells.

  2000cited by this paper
• Higher‐dose and less frequent dendritic cell infusions with PSMA peptides in hormone‐refractory metastatic prostate cancer patients

  2000cited by this paper
• The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides

  2000cited by this paper
• Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

  2000cited by this paper
• The Mechanism of Unresponsiveness to Circulating Tumor Antigen MUC1 Is a Block in Intracellular Sorting and Processing by Dendritic Cells1

  2000cited by this paper
• Dendritic cells at a DNA vaccination site express the encoded influenza nucleoprotein and prime MHC class I-restricted cytolytic lymphocytes upon adoptive transfer.

  2000cited by this paper
• A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use.

  2000cited by this paper
• Macrophage Inflammatory Protein 3α Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors

  2000cited by this paper
• Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1

  2000cited by this paper
• Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.

  2000cited by this paper
• The heat shock protein gp96 induces maturation of dendritic cells and down‐regulation of its receptor

  2000cited by this paper
• The Role of Aquaporins in Dendritic Cell Macropinocytosis

  2000cited by this paper
• Generation of Interferon α–Producing Predendritic Cell (Pre-Dc)2 from Human Cd34+ Hematopoietic Stem Cells

  2000cited by this paper
• Interleukin-1 polymorphisms associated with increased risk of gastric cancer

  2000cited by this paper
• Vaccines against intracellular infections requiring cellular immunity

  2000cited by this paper
• Human Monocyte–Derived Dendritic Cells Induce Naive T Cell Differentiation into T Helper Cell Type 2 (Th2) or Th1/Th2 Effectors

  2000cited by this paper
• Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity

  2000cited by this paper
• Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients.

  2000cited by this paper
• Developmental control of endocytosis in dendritic cells by Cdc42.

  2000cited by this paper
• The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes.

  2000cited by this paper
• Cd4+ T Cell Subsets during Virus Infection

  2000cited by this paper
• In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells.

  2000cited by this paper
• Immunotherapy with Dendritic Cells Directed against Tumor Antigens Shared with Normal Host Cells Results in Severe Autoimmune Disease

  2000cited by this paper
• In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers

  2000cited by this paper
• Large-Scale Culture and Selective Maturation of Human Langerhans Cells from Granulocyte Colony-Stimulating Factor-Mobilized CD34+ Progenitors1

  2000cited by this paper
• The Dendritic Cell Receptor for Endocytosis, Dec-205, Can Recycle and Enhance Antigen Presentation via Major Histocompatibility Complex Class II–Positive Lysosomal Compartments

  2000cited by this paper
• Immature Dendritic Cells Acquire Cd8+Cytotoxic T Lymphocyte Priming Capacity upon Activation by T Helper Cell–Independent or–Dependent Stimuli

  2000cited by this paper
• Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells

  2000cited by this paper
• The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.

  2000cited by this paper
• Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice

  2000cited by this paper

• Ultrasound-mediated targeted micro/nanobubbles: breaking new boundaries in precision tumor therapy.

  2026cites this paper
• Dendritic Cell Cancer Vaccines: A Focused Review.

  2025cites this paper
• Perspective view of allogeneic IgG tumor immunotherapy

  2024cites this paper
• Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy

  2024cites this paper
• Immune Monitoring in Thoracic Malignancies

  2020cites this paper
• Peptide vaccine.

  2020cites this paper
• Physical transfection technologies for macrophages and dendritic cells in immunotherapy

  2020cites this paper
• In vivo Targeting of DNA Vaccines to Dendritic Cells via the Mannose Receptor Induces Long‐Lasting Immunity against Melanoma

  2020cites this paper
• Knowledge is power—Rational design of cancer immunotherapy

  2019cites this paper
• NY-ESO-1 re-directed effector memory and central memory T cells for the treatment of multiple myeloma

  2019cites this paper
• Correlation of Metastasis Location and Outcome in Patients Treated with Checkpoint Inhibitors with NSCLC, RCC and Melanoma

  2019cites this paper
• Palm Tocotrienol-Adjuvanted Dendritic Cells Decrease Expression of the SATB1 Gene in Murine Breast Cancer Cells and Tissues

  2019cites this paper
• Transendothelial migration (TEM) of in vitro generated dendritic cell vaccine in cancer immunotherapy

  2019cites this paper
• Immune Checkpoint Molecules and Cancer Immunotherapy

  2019cites this paper
• Biocompatible Lipid‐Coated Persistent Luminescent Nanoparticles for In Vivo Imaging of Dendritic Cell Migration

  2019cites this paper
• Total tumor RNA pulsed dendritic cells plus adoptive transfer of ex-vivo enriched autologous T-lymphocytes in the treatment of children with primary brain tumors

  2018influential citation
• Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling

  2018cites this paper
• Dendritic cell based vaccination strategy: an evolving paradigm

  2017influential citation
• Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human

  2017cites this paper
• A generic RNA pulsed DC based approach for developing therapeutic intervention against nasopharyngeal carcinoma

  2017cites this paper
• ROR1 as a target for cancer immunotherapy

  2017cites this paper
• Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines.

  2016cites this paper
• Two Heads Are Better Than One: The Combination of Dendritic Cells & B Cells Yields An Improved T Cell Response Over Dendritic Cells Alone When Presenting Tumour Lysate Antigens

  2016cites this paper
• Noncoding RNAs in Cancer Immunology.

  2016cites this paper
• Dendritic Cell Therapy-A promising approach in Cancer treatment

  2016cites this paper
• Flt3 Ligand Induces Monocyte Proliferation and Enhances the Function of Monocyte‐Derived Dendritic Cells In Vitro

  2015cites this paper
• Dendritic Cell Targeting Vaccines

  2015cites this paper
• Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential.

  2015cites this paper
• Using NK Cell Mediated Cytolysis to Trigger Adaptive Immune Responses

  2015cites this paper
• Characteristics and Therapeutic Potential of Menstrual Blood-Derived Stem Cells

  2015cites this paper
• The biomechanical alterations in the CD14+ monocytes of patients with living donor renal transplantation

  2015cites this paper
• Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors

  2015cites this paper
• Autologous Dendritic Cell Based Adoptive Immunotherapy of Patients with Colorectal Cancer—A Phase I-II Study

  2014cites this paper
• Rol de la inflamación sistémica en la patología generada por tumores murinos

  2014cites this paper
• Cancer and the Cellular Immune Response

  2014cites this paper
• Tocotrienol-Adjuvanted Dendritic Cells Inhibit Tumor Growth and Metastasis: A Murine Model of Breast Cancer

  2013cites this paper
• Design and evaluation of theranostic perfluorocarbon particles for simultaneous antigen-loading and ¹⁹F-MRI tracking of dendritic cells.

  2013cites this paper
• HER2/neu-specific Breast Cancer Vaccine

  2013cites this paper
• Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells

  2013cites this paper
• Low Antigen-specific T-cell Response in Pulmonary Tuberculosis is Associated with Impaired Phenotype and Functions of Interferon-α Induced Dendritic Cells

  2013cites this paper
• Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme.

  2013cites this paper
• in HLA Class I and Class II Molecules Cells Presenting MAGE-A3 Simultaneously Messenger RNA-Electroporated Dendritic

  2013cites this paper
• Production of canine soluble CD40 ligand to induce maturation of monocyte derived dendritic cells for cancer immunotherapy.

  2013cites this paper
• for the adoptive Immunotherapy of EBV-associated malignancies Generating CTL against the subdominant Epstein-Barr virus LMP1 antigen

  2013cites this paper
• Relationship of TGF‐β1 and Smad7 expression with decreased dendritic cell infiltration in liver gastrointestinal cancer metastasis

  2013cites this paper
• malignancies antigen for the adoptive immunotherapy of EBV-associated Generating CTLs against the subdominant Epstein-Barr virus LMP1

  2013cites this paper
• Combination Therapy of Cancer – Escalating the Effect of Dendritic Cell-based Cancer Vaccine in the Tumour Micro-environment

  2012cites this paper
• Brain dendritic cells: biology and pathology

  2012cites this paper
• HUMAN ENDOGENOUS RETROVIRUS K AS A NOVEL TUMOR-ASSOCIATED ANTIGEN FOR DEVELOPMENT OF AN OVARIAN CANCER VACCINE

  2012cites this paper
• The Potential Use of Triterpene Compounds in Dendritic Cells-Based Immunotherapy

  2012cites this paper
• Role of dendritic cells in progression and clinical outcome of colon cancer

  2012cites this paper
• Tumour Vaccine Approaches for CNS Malignancies

  2012cites this paper
• Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti‐tumour immunity

  2012cites this paper
• Role of tyrosine kinase inhibitors in tumor immunology.

  2011cites this paper
• mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells.

  2011cites this paper
• Investigating lesions of Langerhans cells and their role in lymphoproliferative diseases

  2011cites this paper
• Dendritic cell-tumor cell hybrids and immunotherapy: what's next?

  2011cites this paper
• Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma.

  2011cites this paper
• Investigational Approaches for Mesothelioma

  2011cites this paper
• In Vivo Modulation of Dendritic Cells by Engineered Materials: Towards New Cancer Vaccines.

  2011cites this paper
• Guiding the “misguided” – functional conditioning of dendritic cells for the DC‐based immunotherapy against tumours

  2011cites this paper
• Production of functional dendritic cells from menstrual blood—a new dendritic cell source for immune therapy

  2011cites this paper
• Stem Cell Tracking in Human Trials: A Meta-Regression

  2011cites this paper
• Antigen presentation : Influence of Cell Type and Route of Antigen Uptake

  2011cites this paper
• Estudo da resposta imunológica desencadeada por células de cancro de bexiga que expressam antigénios sialil-Tn

  2010cites this paper
• The Clinical Impact of the Dendritic Cell-based Cancer Vaccine: the Role in the Inflammatory Tumor Micro-environment

  2010cites this paper
• Ovarian cancer immunotherapy: opportunities, progresses and challenges

  2010cites this paper
• Frequenzanalyse von tumorspezifischen T-Zellen nach Hybridzellvakzinierung bei Melanompatienten

  2010cites this paper
• Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer Immunotherapy

  2010cites this paper
• Increased Tumor-Specific CD8+ T Cell Induction by Dendritic Cells Matured with a Clinical Grade TLR-Agonist in Combination with IFN-γ

  2010cites this paper
• Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.

  2010cites this paper
• Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

  2010cites this paper
• Ursolic acid isolated from Uncaria rhynchophylla activates human dendritic cells via TLR2 and/or TLR4 and induces the production of IFN-gamma by CD4+ naïve T cells.

  2010cites this paper
• Dendritic cell vaccines for brain tumors.

  2010influential citation
• Current Status of Immunotherapy for Osteosarcoma and its Future Trends

  2010cites this paper
• Enhancement of Extracts from Celastrus orbiculatus on Maturation and Function of Dendritic Cells in vitro and in vivo

  2010cites this paper
• Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.

  2010cites this paper
• Effekte von Prostaglandin E2 und EP-Rezeptoragonisten auf die Ausreifung, Antigenaufnahme und Antigenpräsentation von humanen Monozyten-abgeleiteten dendritischen Zellen

  2010cites this paper
• Dendritic Compounds as Immune Response Modulators. New Approaches for Vaccine Development

  2009cites this paper
• Systemic effects of local radiotherapy.

  2009cites this paper
• Mutual Helper Effect in Copulsing of Dendritic Cells With 2 Antigens: A Novel Approach for Improvement of Dendritic-based Vaccine Efficacy Against Tumors and Infectious Diseases Simultaneously

  2009cites this paper
• Antitumor activity of G3139 lipid nanoparticles (LNPs).

  2009cites this paper
• In vivo generation of 'vaccination nodes' using injectable alginate hydrogels for cancer immunotherapy

  2009cites this paper
• Uric Acid as a Growth Factor for Activated B Cells

  2009cites this paper
• Modification of Dendritic Cells to Enhance Cancer Vaccine Potency

  2009cites this paper
• Future Directions in Dendritic Cell Research in Cancer

  2009cites this paper
• Attenuated Expression of A20 Markedly Increases the Efficacy of Double-Stranded RNA-Activated Dendritic Cells As an Anti-Cancer Vaccine1

  2009cites this paper
• TLR9 Signaling Promotes Tumor Progression of Human Lung Cancer Cell In Vivo

  2009cites this paper
• Lymphangiogenesis and anti-tumor immune responses.

  2009cites this paper
• Improved transfection of spleen-derived antigen-presenting cells in culture using TATp-liposomes.

  2009cites this paper
• Dendritic cells: therapy and imaging

  2009cites this paper
• Dendritic cell immunotherapy for HIV infection: from theory to reality.

  2009cites this paper
• The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy.

  2009cites this paper
• Cellular immunotherapy (CI), where have we been and where are we going?

  2009cites this paper
• Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges.

  2009cites this paper
• Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.

  2009cites this paper
• RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma

  2008cites this paper
• Different types of in vitro generated human monocyte‐derived dendritic cells release exosomes with distinct phenotypes

  2008cites this paper
• Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy.

  2008cites this paper
• Dendritic Cells Promoted by Ginseng Saponins Drive a Potent Th1 Polarization

  2008cites this paper